You are here

Instant Injury Immobilization for Temporary Return to Duty

Award Information
Agency: Department of Defense
Branch: Defense Health Agency
Contract: W81XWH21C0062
Agency Tracking Number: H2-0631
Amount: $1,499,714.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: DHA193-005
Solicitation Number: 19.3
Solicitation Year: 2019
Award Year: 2021
Award Start Date (Proposal Award Date): 2021-05-24
Award End Date (Contract End Date): 2023-09-23
Small Business Information
330 Billerica Road Ste 200
CHELMSFORD, MA 01824-0440
United States
DUNS: 796010411
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 James Saunders
 (978) 856-4164
Business Contact
 Collette E Jolliffe
Phone: (978) 856-4158
Research Institution

81.1% of MEDEVAC in OIF/OEF were due to non-battle injury related injury with musculoskeletal injuries as leading cause. Many of these injuries will need to be managed in the operational environment without MEDEVAC. Future multi-domain battle operations against peer/near-peer adversaries will restrict MEDEVAC of injured warfighters necessitating care closer to the point of injury. Triton will develop and demonstrate a novel splinting system that allows casualties with lower extremity MSI to return to duty.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government